Skip to main content
Clinical Trials/CTRI/2017/09/009859
CTRI/2017/09/009859
Recruiting
未知

Efficacy of topical ocular hypotensive agents in arresting progression of Keratoconus.

I0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Keratoconus
Sponsor
I
Enrollment
120
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • Patients between 15 to 30 years of age with a definitive diagnosis of keratoconus as in accordance with guidelines of Collaborative Longitudinal Evaluation of Keratoconus Group

Exclusion Criteria

  • Patients with associated ocular surface disease
  • Systemic disorders like bronchial asthma cardiovascular disorders
  • Pre existing glaucoma or use of antiglaucoma drugs
  • H/o prior treatment with collagen cross linking
  • H/o prior corneal hydrops
  • History of use of contact lens in the last 3 weeks
  • Pregnancy or lactation during the period of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials